_edited.jpg)
Prenatal SafeKaryo Plus COMPLETE
£1,400.00
Prenatalsafe® NIPT is a non-invasive prenatal test that enables the analysis of fetal genetic material from a
routine blood sample taken from the mother. Depending on the test chosen, it allows for the testing of aneuploidies, microdeletion syndromes and single gene disorders.
- IT'S SIMPLE
A simple blood sample at 10+ week of pregnancy, from which the circulating fetal DNA is analysed. - IT'S RELIABLE
99.9% sensitivity for trisomy 21,18 13 (Pertile et al., 2021). - IT'S SAFE
It is a non-invasive test, no risk to the fetus or the mother. - IT'S SENSITIVE
It allows detecting chromosomal aneuploidies even at low quantities of fetal DNA (2%), unlike other tests that require a quantity of fetal DNA> 4%. - IT'S QUICK
Thanks to the new high-resolution FAST technology, the PrenatalSAFE test results will be available from 3 working days (for the standard Prenatalsafe® 3 & 5 tests). - IT'S CLEAR
Prenatalsafe® is the non-invasive prenatal test that provides the clearest results: aneuploidy DETECTED or aneuploidy NOT-DETECTED, within the limits of resolution of the method
Standard Turnaround time:
Date of Birth
Quantity
Biomarkers checked
Down Syndrome (Trisomy 21)
Edwards Syndrome (Trisomy 18)
Patau Syndrome (Trisomy 13)
Turner Syndrome (XO)
Klinefelter syndrome (XXY)
Jacobs Syndrome (XYY)
Triple X syndrome (XXX)
Rare Autosomal Aneuploidies = abnormalities involving all chromosomes besides 21,18,13,X and Y.
Deletions and Duplications in any chromosome. These are missing or gained pieces of chromosomes (>7Mb)
9 different Microdeletion syndromes: 1p36 (1p36 deletion syndrome), 4p- (Wolf-Hirschhorn syndrome), 5p-(Cri-du-Chat syndrome), 15q11.2 (Prader-Willi / Angelman syndrome), 22q11.2 (DiGeorge syndrome), 8q24 (Langer-Giedion syndrome), 11q23 (Jacobsen syndrome) and 17p11.2 (Smith-Magenis syndrome)
The test will also screen for 45 ‘gene disorders’ including cystic Fibrosis, deafness, beta-thalassemia, sickle cell anaemia and other De Novo disorders. These results will be available 10 days following the initial chromosomal results.
The test will also screen for 45 ‘gene disorders’ including cystic Fibrosis, deafness, beta-thalassemia, sickle cell anaemia and other De Novo disorders. These results will be available 10 days following the initial chromosomal results.
Pre-test
consultation for all patients can be offered and post-test
consultation with a Clinical Scientist if high-risk result.
Collection method
Maternal Blood
When is testing suitable?
- At or after 10 weeks: The test is performed on a maternal blood sample and is suitable for both singleton and identical twin pregnancies.
- For vanishing twins: You should wait at least 5 weeks from when the vanishing twin was detected before taking the test.
- Before 10 weeks: The test is not suitable before this time.
Laboratory processing time
Standard Turnaround time: 10-12 working days
How does it work?
1. Order Prenatal Test Kit online or from clinic
2. Receive the kit
3. Consultation with doctor
4. Produce a Maternal blood sample
5. Post the sample kit to a Post Box
6. Results via password protected email and discussion of abnormal results and recommended management plan.
7.Pre-testconsultation for all patients can be offered and post-testconsultation with a Clinical Scientist if high-risk result.
Accreditations
Labs are based in Italy/UK ISO 9001:2015,ISO 17025,UNI EN ISO 15189:2013
Distributed in the UK by Biox Medical Ltd